Background/Aims: MicroRNA-21 (miR-21) has been demonstrated to play an important role in carcinogenesis; however, its mechanism of action in colorectal cancer (CRC) has not been fully elucidated. The aim of the present study was to explore the oncogenic function of miR-21 and its molecular mechanism in CRC. Methods: A total of 105 paired tumor and tumor-adjacent normal tissue specimens from CRC patients and two CRC cell lines (HCT-116 and SW480) were studied. The protein and mRNA expression levels of PTEN and miR-21 were examined using western blot analysis and real-time reverse transcription-PCR (qRT-PCR). Furthermore, we transfected CRC cells with different combinations of ectopic-expression vector or shRNA expression vector of miR-21 and phosphatase and tensin homolog (PTEN) to modulate the expression levels of miR-21 and PTEN respectively, and then analyzed the phenotypic alterations of CRC cells. Tumorigenesis was also evaluated by xenografting HCT-116 cells into nude mice. Results: In this study, we showed that miR-21 expression was significantly up-regulated in CRC compared to that in normal tissues. Patients with advanced Tumor-Node-Metastasis (TNM) stage, lymph node metastasis, local invasion and higher serum carcinoembryonic antigen (CEA) levels displayed significantly high expression of miR-21. The PTEN protein level in CRC tissues and cells was inversely correlated with miR-21 expression. Furthermore, the transfection of CRC cells with pre-miR-21 could inhibit apoptosis and promote cellular proliferation, invasion, cell cycle progression and growth of xenografts in nude mice, whereas the transfection of miR-21-specific shRNA resulted in the opposite phenomena. In addition, silencing or elevating PTEN protein could partially reverse the effect of miR-21-specific shRNA or pre-miR-21 on apoptosis, cell cycle distribution, and invasion of CRC cells. Moreover, over-expression or knockdown of miR-21 altered the protein expression
Introduction
Colorectal cancer (CRC) is one of the most common malignancies and a leading cause of cancer-related death worldwide [1] . Surgical resection and chemoradiotherapy are still the primary therapeutic approaches for CRC; however, 25%-30% of patients are diagnosed too late to be eligible for resection. Moreover, 30%-50% patients with CRC will develop recurrence and metastasis, with more than 90% of the recurrences in the first 5 years following surgery. The outcomes of patients diagnosed with CRC remain quite poor [2, 3] . Analysis of the genome and proteome of CRC cells has demonstrated that focusing on molecular heterogeneity in colorectal carcinogenesis may provide a viable target and approach for the clinical diagnosis and therapy of CRC. Numerous studies and resources have been dedicated to elucidate the molecular mechanisms of CRC. However, the molecular pathogenesis of CRC is complicated and remains unclear.
MicroRNAs (miRNAs) are endogenously expressed short, noncoding, single-stranded RNAs of 18-25 nucleotides in length. In general, miRNAs are transcribed as a cluster called the pri-miRNA complex, which is cleaved in the nucleus to form the pre-miRNA that is then translocated to the cytoplasm to undergo final maturation into a functional miRNA. miRNAs can modulate gene expression at the post-transcriptional level by targeting mRNAs for translational repression or degradation. Many studies have demonstrated that miRNAs play key roles in the regulation of cellular growth, differentiation, proliferation, and apoptosis [4] . Furthermore, it has been shown that miRNAs can function as tumor suppressors or oncogenes and are involved in various biological processes such as tumor initiation, tumor progression and drug resistance in various types of cancer, including CRC [5] [6] [7] [8] [9] [10] . miR-21, a putative oncogene, is most frequently over-expressed in various malignancies, and it has been implicated in multiple malignancy-related processes including uncontrolled cell proliferation, inhibition of apoptosis and promotion of invasion and metastasis [11] [12] [13] . According to recent reports, several significant targets of miR-21 associated with malignancy have been experimentally validated, such as PTEN [14] [15] [16] [17] [18] [19] [20] , programmed cell death 4 (PDCD4) [21] [22] [23] , reversion-inducing cysteine-rich protein with Kazal motifs (RECK) [24] , forkhead box O1 (FOXO1) [25] , RhoB [26] and Cdc25a [27] , and these targets may exert different effects on tumorigenesis. Among them, the PTEN protein was reported to be frequently silenced in CRC, and it has been shown to suppress tumor formation by inhibiting the PI3K/AKT pathway [28, 29] . Therefore, miR-21 might act as an important oncogene by regulating PTEN as one of its several target genes and thus may be a useful biomarker for the diagnosis and treatment in CRC.
Previous studies have shown that miR-21 is up-regulated in CRC and functions as an oncogene. However, the biological roles and exact mechanisms of miR-21 in the carcinogenesis and development of CRC remain elusive. The aim of the present study was to explore the oncogenic function of miR-21 and its molecular mechanisms in CRC. In this study, we determined the expression of miR-21 and PTEN protein in human CRC tissues and correlated them with clinicopathological features of CRC patients. Subsequently, in order to evaluate the role of miR-21 in the proliferation, apoptosis, cell cycle distribution and invasion of CRC cells, as well as its effect on target genes, the recombinant ectopic-expression and short hairpin RNA (shRNA)-expression plasmids of miR-21 and PTEN were constructed, and transfected individually or together into the CRC cell lines HCT-116 and SW480. Finally, we demonstrated the effects of miR-21 on tumor formation and the regulatory mechanism of miR-21 in vivo in a human CRC model using nude mice. The results of this study may improve
Plasmid constructs and transfection
To construct the recombinant ectopic-expression and shRNA-expression plasmids of miR-21 and PTEN, the corresponding gene sequences encoding pre-miR-21 and PTEN were amplified from HCT-116 cells and cloned into the pEGFP-N1 vector (Invitrogen, USA), and the shRNA sequences of miR-21 and PTEN, as well as the scrambled control sequences, were designed and cloned into the Psilencer4.1-CMV vector (Invitrogen, USA). Consequently, the ectopic-expression plasmids pEGFP-pre-miR-21 (pE-miR-21) and pEGFP-PTEN (pE-PTEN) for the over-expression miR-21 and PTEN, respectively, and the shRNA-expression plasmids Psilencer4.1-miR-21-shRNA (miR-21 shRNA) and Psilencer4.1-PTEN-shRNA (PTEN shRNA) to knock down miR-21 and PTEN, respectively, were constructed. Then, in order to explore the functional role of miR-21 in CRC, the ectopic-expression or shRNA-expression plasmids for miR-21 and PTEN was transfected alone or together into the CRC cell line HCT-116 or SW480 using Lipofectamine 2000 (Invitrogen, USA) according to the manufacturer's instructions. The expression of miR-21 and PTEN was verified using real-time PCR 48 h after transfection. Stable cell lines (HCT-116 cells transfected with null vector pEGFP-N1, pE-miR-21, miR-21 shRNA or scrambled sequence control) were selected with 600 µg/ml of G418, and the expression of miR-21 was also confirmed using real-time PCR.
RNA isolation and real-time PCR
Total RNA was isolated from cells and tissues using TRIzol reagent (Invitrogen, USA) according to manufacturer's instructions. One microgram of total RNA was reverse-transcribed to cDNA using the RevertAid TM First Strand cDNA Synthesis Kit (Fermentas, USA). miR-21 and the reference gene U6 were amplified using gene-specific stem-loop primers. The cDNA was used for the quantification of miR-21 and PTEN. Real-time PCR was performed using SYBR Premix Ex Taq™ (Takara, Japan) according to the manufacturer's protocol. The reactions were carried out using an Applied Biosystems 7500 Fast Real-time PCR system (Applied Biosystems Inc., USA). For estimating the differential expression of miR-21 and PTEN mRNA, the Ct values were normalized using U6 and GAPDH mRNA, respectively, as internal controls. Primer sequences for miR-21 (RT-primer: 5'-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACTCAACA-3'; forward: 5'-CGGCGGTAGCTTATCAGACTGATGT-3'; reverse: 5'-GTGCAGGGTCCGAGGT-3'), U6 (RTprimer:
5'-CGCTTCACGAATTTGCGTGTCAT-3'; forward: 5'-CTCGCTTCGGCAGCACA-3'; reverse: 5'-AACGCTTCACGAATTTGCGT-3'), PTEN (forward: 5'-ACCATAACCCACCACAGC-3'; reverse: 5'-CAGTTCGTCCCTTTCCAG-3'), and GAPDH (forward: 5'-ACGGATTTGGTCGTATTGGG-3'; reverse: 
Western blot
Cells or tissues were harvested and lysed in lysis buffer on ice for 30 min. The lysate was centrifuged at 12, 000 rpm at 4°C for 15 min, and protein concentrations were measured with a protein assay kit (Bio-Rad, USA). Equal amounts of proteins were electrophoresed using SDS-PAGE gels and subsequently transferred to PVDF membranes (Bio-Rad laboratories, USA). After blocking with 5% bovine serum albumin (BSA) at 4°C overnight, the membranes were incubated with antibodies against PTEN, p-AKT and β-actin (Santa Cruz, USA) in TBST at room temperature for 2 h. After washing three times with TBST, the membranes were incubated with peroxidase-conjugated secondary antibodies (Santa Cruz, USA) for 1 h, and then the protein signals were detected with electrochemiluminescence (ECL) western blot detection reagents (Beyotime, China). Expression levels of the proteins were compared to the control based on the relative intensities of the bands. Band density was quantified using the Bio-Rad Quantity One v4.62 software.
Cell proliferation assay
Cell proliferation was determine using the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT; Sigma, USA) assay. Cells were plated in 96-well plates at 5×10 3 cells per well and transfected with recombinant plasmids or non-specific control plasmids. After incubation for 24 h, 20 μl of the MTT solution was added to each well and incubated for 4 h at 37°C. The supernatant was removed, and the formazan crystals was dissolved in 100 µl DMSO. The absorbance of the suspension was measured at 570 nm at 24, 48, 72, 96 h after transfection.
Flow cytometric analysis
Cell cycle distribution and apoptosis were evaluated using flow cytometric analysis. Briefly, cells were harvested 48 h after transfection. For cell cycle analysis, the transfected cells were washed with cold PBS and fixed in 70% ethanol overnight at 4°C. The next day, the cells were incubated with 0.01% RNase at 37°C for 10 min and then stained with 50 μg/mL propidium iodide (PI) at 4°C in the dark for 20 min. Cell cycle distribution was examined with a FACSCalibur Flow Cytometer (Becton Dickinson, USA). Meanwhile, the transfected cells were dual-stained with the viability dye 7-amino-actinomycin D (7-AAD) and Annexin V-APC using an Annexin V-APC/7-AAD Apoptosis Detection Kit (KaiJi, China) following the manufacturer's protocol. The stained cells were immediately analyzed using flow cytometry.
Cell invasion assay
Cell invasion was examined using 24-well Matrigel-coated transwell chambers (Becton Dickinson, USA). In brief, cells were washed with PBS and resuspended at 1×10 5 cells/mL in serum-free medium 24 h after transfection. Then, 0.2 ml cell suspension was added to the upper chamber, and 0.5 ml medium containing 10% FBS was added to the lower chamber. After incubation for 24 h, all non-invaded cells were removed from upper surface of the filters, and the invaded cells were fixed and stained with crystal violet solution. The experiments were performed in triplicate, and the invaded cells were counted under a microscope (400×) in five different fields per filter.
Tumor xenografts
Forty 4-to 5-week-old female athymic nude mice were divided into 5 groups as follows: pE-miR-21, miR-21 shRNA, scrambled control, null vector control, and negative control (inoculated with untreated HCT-116 cells). Stably transfected HCT-116 cells were resuspended in PBS and subcutaneously inoculated into the right axilla of mice (1×10 7 cells/mouse). Mice were maintained in a pathogen-free environment. From day 4, tumor volume (V) was measured every other day and calculated according to the formula V (mm 
Results

miR-21 over-expression is associated with clinicopathological features of CRC patients
The expression of miR-21 in 105 paired CRC and corresponding normal tissues was measured using real-time PCR. Compared to the normal tissues, we found significantly higher miR-21 expression of up to 3.45-fold in CRC (P<0.01). The median gene expression of miR-21 in the CRC samples was 5.03, and the median gene expression in the normal mucosa tissue was 1.22. 
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Furthermore, miR-21 expression was significantly higher in patients with advanced clinical TNM stage, poor differentiation, deeper invasion, positive lymphatic metastasis and high level of serum CEA. However, non-significant differences were observed in sex, age and tumor location. The patient characteristics along with the relative expression of miR-21 in the CRC samples obtained using real-time PCR are shown in Table 1 . miR-21 expression was associated with TNM stage (P<0.01), histological differentiation (P<0.01), depth of invasion (P<0.01), lymph node metastasis (P<0.01) and serum CEA level (P<0.01) but not sex, age and tumor location.
PTEN protein level is inversely correlated with miR-21 expression in CRC tissues
To explore miR-21 target genes, we examined the protein expression of the tumor suppressor gene PTEN using western blotting. Among the 105 pairs of matched CRC specimens, 16 pairs were chosen for the evaluation of the correlation between miR-21 levels Figure 1a and 1b. Moreover, we found a significant inverse correlation between the levels of miR-21 and PTEN protein (Fig. 1c) (r=-0.694, P<0.01).
miR-21 regulates the expression of PTEN and phosphorylation of AKT
To further explore whether PTEN expression is regulated by miR-21 in CRC cells, we analyzed the expression of miR-21 and PTEN in HCT-116 and SW480 cells transiently transfected with pE-miR-21, miR-21 shRNA, scrambled sequences (scramble), null vector control (null) or blank control containing culture medium (Mock). As shown in Fig. 2a and  2c , the elevation or reduction of endogenous miR-21 levels with pE-miR-21 or miR-21 shRNA plasmids, respectively, resulted in a corresponding decrease or increase in PTEN protein expression relative to that in the control cells. However, there was no change in PTEN mRNA levels (Fig. 2b) . As p-AKT is an important downstream target of PTEN, the changes in p-AKT was also simultaneously examined. As shown in Fig. 2c , the phosphorylation of Akt was also concomitantly increased or decreased in response to pE-miR-21 or miR-21 shRNA, which mimicked the effect of PTEN shRNA or pE-PTEN.
In addition, the regulation of PTEN by miR-21 was further confirmed in CRC xenograft tumors in nude mice. Consistent with the in vitro data, miR-21 reduced the protein expression of PTEN and elevated the phosphorylation of Akt, but the mRNA level of PTEN in tumors was not changed (Fig. 3) .
miR-21 promotes proliferation in CRC cell lines
The MTT assay was used to evaluate the effect of miR-21 on cell proliferation. The results showed that the over-expression of miR-21 with pE-miR-21 plasmid could promote The expression of PTEN mRNA in xenograft tumor was examined using real-time PCR. The results were normalized to GAPDH expression and expressed as fold change relative to those in the negative control. (c) The expression of PTEN protein and the phosphorylation of AKT in xenograft tumors were examined using western blot analysis. The results were normalized to β-actin protein expression and expressed as fold change relative to those in the negative control. The band intensity was analyzed using Bio-Rad Quantity One v4.62 software. All data are representative of three independent experiments. **p<0.01 vs negative control. 
miR-21 regulates cell cycle distribution and apoptosis in CRC cells through PTEN
To better understand the biological effects of miR-21 on CRC cells, we evaluated the cell cycle distribution and apoptosis using flow cytometry. As shown in Fig. 5 , a decrease in apoptosis was observed in both HCT-116 and SW480 cells transfected with pE-miR-21, and an increase was observed in response to miR-21 shRNA. Meanwhile, an increase in the population of cells in S phase was observed for both cell lines transfected with pE-miR-21, and a decrease was observed in response to miR-21 shRNA (Fig. 6) .
To further investigate whether miR-21 regulates cell cycle distribution and apoptosis in CRC cells by down-regulating PTEN, pE-miR-21-or miR-21 shRNA-transfected cells were co-transfected with pE-PTEN or PTEN shRNA. As shown in Fig. 5 and Fig. 6 , the decrease in apoptosis and increase in the proportion of cells in S phase by pE-miR-21 were partially reversed by the over-expression of PTEN with pE-PTEN. In contrast, the increase in apoptosis and decrease in the proportion of cells in S phase by miR-21 shRNA were partially reversed by the knockdown of PTEN via its shRNA. These data indicated that miR-21 might accelerate cell cycle progression and inhibit apoptosis of CRC cells by down-regulating PTEN.
miR-21 regulates invasion of CRC cells through PTEN
The Chemicon cell invasion assay was employed to examine the effect of miR-21 on the invasiveness of CRC cells. The results clearly indicated that over-expression of miR-21 with pE-miR-21 in CRC cells could promote invasion. In contrast, inhibition of miR-21 activity with miR-21 shRNA led to a significant decrease in motility of CRC cells (Fig. 7) . Furthermore, we conducted co-transfection experiments to examine whether miR-21 affects cellular invasion by regulating PTEN in CRC cells. We observed that silencing of PTEN with shRNA inhibited the effect of miR-21 shRNA and led to an increase in motility of CRC cells, and over-expression of PTEN with pE-PTEN inhibited the effect of pE-miR-21 treatment and led to a decrease in cell motility. These results suggested that miR-21 promoted the invasiveness of CRC cells by down-regulating PTEN. 
miR-21 modulates the growth of CRC xenografts
As miR-21 regulates the growth of CRC cells in vitro, we further assessed its effect on tumor formation in vivo. After selection in antibiotics for four months, stable clones were obtained. The expression of miR-21 was found to be increased or decreased in the stable clones transfected with pE-miR-21 or miR-21 shRNA as shown in Fig. 8c . The implanted tumors were noticeable 7 days after injection. Compared with the negative group, overexpression miR-21 significantly promoted tumor growth. Conversely, suppression of miR-21 markedly reduced tumor size (Fig. 8a) and tumor weight (Fig. 8b) .
Discussion
miRNAs are small, noncoding RNAs that can negatively regulate gene expression at the translational level by base pairing with the 3' untranslated region (3'-UTR) of target mRNAs. With the increase in the number of studies on miRNAs, the aberrant expression of miRNAs has been identified in different types of cancer. miRNAs can function as tumor suppressors or oncogenes and regulate numerous important cancer-related genes. Over-expression of miRNAs can result in the down-regulation of tumor suppressor genes, whereas silencing of miRNAs can lead to the up-regulation of oncogenes [4, 5] . Recently, a large number of miRNAs have been reported to be dysregulated in CRC and to affect tumor growth, migration and invasion by regulating certain genes [30] [31] [32] [33] [34] .
miR-21 is one of the most prominent miRNAs implicated in the genesis and progression of human malignancy. Its expression is notably up-regulated in many cancers, including CRC, lung cancer, glioblastoma, hepatocellular carcinoma, and gastric cancer. In addition, its elevated expression level has been causally associated with tumor aggressiveness and poor prognosis [17-19, 24, 25, 35-39] . Numerous reports have demonstrated that miR-21 acts as a potential oncogene in CRC by promoting tumorigenesis, invasion and metastasis. For Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry example, Yamamichi et al. have found that miR-21 expression was much higher in CRC tissue than that in normal mucosa. Meanwhile, significantly elevated expression of miR-21 has been observed in precancerous adenomas but not in nontumorigenic polyps. It has been indicated that miR-21 expression progressively increases during CRC progression from precancerous adenoma to advanced carcinoma [35] . In addition, the high expression of miR-21 and its association with advanced clinical stage, lymph node positivity and distal metastasis in CRC have been demonstrated in several studies [36] [37] [38] . Upon further study of the biological effects of miR-21, Liu et al. indicated that over-expression of miR-21 significantly promotes proliferation and invasion and inhibits apoptosis in human CRC cells, which may suggest its function as an oncogene in CRC [26] . In agreement with previous reports, our findings have shown that miR-21 is significantly up-regulated in CRC and is associated with advanced clinical TNM stage, poor differentiation, deeper invasion, positive lymph node metastasis and high level of serum CEA. Because our clinical data suggested that miR-21 was related to the progression of CRC, we further investigated its biological function by transfecting CRC cells with ectopic-expression or shRNA-expression plasmids of miR-21. The results indicated that miR-21 could promote cell proliferation, accelerate cell cycle progression, inhibit apoptosis, and induce invasion of CRC cell lines. We further confirmed that miR-21 promotes the growth of CRC xenografts in nude mice in vivo. These findings suggested that miR-21 might promote malignant phenotypes in CRC, and hence it can be used as a potential biomarker for early diagnosis and treatment of CRC. The tumor suppressor PTEN has been shown to be frequently mutated in a large number of human cancers, including CRC [28] . It has been reported that PTEN may function as a dual specificity phosphatase and regulate cell growth, apoptosis, invasion and differentiation by negatively regulating the PI3K/AKT signaling pathway. PTEN can When PTEN is deleted, mutated, or inactivated, the activation of the PI3K/AKT signaling pathway can be triggered by numerous endogenous and exogenous stimuli, and this can promote the development of cancer. This pathway is known to play a key role in numerous cellular functions including proliferation, adhesion, angiogenesis, migration, invasion, and metabolism [40] [41] [42] . Further, loss of PTEN expression has been indicated to be significantly associated with advanced TNM stage, distant metastasis and poor prognosis in CRC [28, 29] . PTEN has also been reported as a direct target of miR-21, and it has been shown to be involved in miR-21-mediated cell proliferation, apoptosis inhibition, and invasion in human hepatocellular carcinoma [24] , non-small cell lung cancer (NSCLC) [17] , gastric cancer [18] , endometrial cancer [19] and nasopharyngeal carcinoma [20] . Moreover, Xiong et al. observed a significant inverse correlation between miR-21 and PTEN protein in CRC tissues and cells and demonstrated that PTEN was a direct target of miR-21 in CRC through dual-luciferase reporter assays [16] . Our study showed that PTEN protein expression was significantly reduced in CRC tumor tissues and negatively correlated with the expression of miR-21, which was consistent with the results of previous studies. Moreover, we found that miR-21 could decrease PTEN protein expression and increase Akt phosphorylation in CRC cells. Furthermore, for the first time, we demonstrated the down-regulation of PTEN protein by miR-21 in CRC xenografts in nude mice.
Although the oncogenic function of miR-21 and the regulation of PTEN in CRC have been known, there was no direct evidence to affirm whether or not the miR-21-mediated malignant phenotypes of CRC cells were caused by PTEN. A previous study established a "rescue method" in which an miRNA inhibitor and specific siRNAs against its target gene were co-transfected into cells to modulate the protein level of the target and thus determine whether the miRNA affects cell phenotypes by the direct regulation of its target [24] . On the basis of this strategy, we developed a method that could bidirectionally change the protein level of PTEN by co-transfecting different combinations of the ectopic-expression or shRNAexpression plasmids of miR-21 and PTEN into CRC cells as follows: pE-miR-21 + pE-PTEN and miR-21-shRNA + PTEN-shRNA. Then, we detected the alterations in cell phenotypes in the different groups. Through a series of in vitro experiments, we found that silencing or elevating PTEN protein expression could partially reverse the effect of miR-21 shRNA or pE-miR-21 on apoptosis, cell cycle distribution, and invasion of CRC cells. Together with the previous findings, these results suggest that miR-21 might play an oncogenic role in the proliferation, apoptosis, cell cycle distribution and invasion of CRC cells by reducing PTEN protein levels and subsequently elevating Akt phosphorylation.
In conclusion, miR-21 plays an oncogenic role in the development and progression of CRC. It modulates malignant phenotypes such as proliferation, anti-apoptosis, cell cycle progression and invasion in CRC cells by down-regulating PTEN protein expression. Therefore, these data can help us understand the molecular mechanisms of miR-21 in CRC and provide valuable insights into the clinical use of miR-21 as a biomarker in this type of cancer.
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